NASDAQ
OPRX

OPTIMIZERx Corp

Health Information Services
Healthcare

Prices are adjusted according to historical splits.

OPTIMIZERx Corp Stock Price

Vitals

Today's Low:
$7.61
Today's High:
$8.15
Open Price:
$8.11
52W Low:
$7.24
52W High:
$22.77
Prev. Close:
$8.12
Volume:
185159

Company Statistics

Market Cap.:
$140.59 million
Book Value:
6.962
Revenue TTM:
$61.56 million
Operating Margin TTM:
-26.91%
Gross Profit TTM:
$38.97 million
Profit Margin:
-23.31%
Return on Assets TTM:
-7.71%
Return on Equity TTM:
-11.19%

Company Profile

OPTIMIZERx Corp had its IPO on 1996-10-22 under the ticker symbol OPRX.

The company operates in the Healthcare sector and Health Information Services industry. OPTIMIZERx Corp has a staff strength of 109 employees.

Stock update

Shares of OPTIMIZERx Corp opened at $8.11 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $7.61 - $8.15, and closed at $7.73.

This is a -4.8% slip from the previous day's closing price.

A total volume of 185,159 shares were traded at the close of the day’s session.

In the last one week, shares of OPTIMIZERx Corp have slipped by -10.84%.

OPTIMIZERx Corp's Key Ratios

OPTIMIZERx Corp has a market cap of $140.59 million, indicating a price to book ratio of 2.4517 and a price to sales ratio of 4.7592.

In the last 12-months OPTIMIZERx Corp’s revenue was $61.56 million with a gross profit of $38.97 million and an EBITDA of $-14661902. The EBITDA ratio measures OPTIMIZERx Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, OPTIMIZERx Corp’s operating margin was -26.91% while its return on assets stood at -7.71% with a return of equity of -11.19%.

In Q2, OPTIMIZERx Corp’s quarterly earnings growth was a negative -66.8% while revenue growth was a negative 1.1%.

OPTIMIZERx Corp’s PE and PEG Ratio

Forward PE
31.1526
Trailing PE
0
PEG
2.0751

Its diluted EPS in the last 12-months stands at $-0.82 per share while it has a forward price to earnings multiple of 31.1526 and a PEG multiple of 2.0751. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into OPTIMIZERx Corp’s profitability.

OPTIMIZERx Corp stock is trading at a EV to sales ratio of 3.7891 and a EV to EBITDA ratio of -27.38. Its price to sales ratio in the trailing 12-months stood at 4.7592.

OPTIMIZERx Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$121.32 million
Total Liabilities
$5.51 million
Operating Cash Flow
$3.22 million
Capital Expenditure
$1.10 million
Dividend Payout Ratio
0%

OPTIMIZERx Corp ended 2024 with $121.32 million in total assets and $0 in total liabilities. Its intangible assets were valued at $121.32 million while shareholder equity stood at $115.82 million.

OPTIMIZERx Corp ended 2024 with $0 in deferred long-term liabilities, $5.51 million in other current liabilities, 18377.00 in common stock, $-57251261.00 in retained earnings and $22.67 million in goodwill. Its cash balance stood at $9.81 million and cash and short-term investments were $62.74 million. The company’s total short-term debt was $14,545 while long-term debt stood at $0.

OPTIMIZERx Corp’s total current assets stands at $85.07 million while long-term investments were $0 and short-term investments were $52.93 million. Its net receivables were $18.28 million compared to accounts payable of $3.54 million and inventory worth $0.

In 2024, OPTIMIZERx Corp's operating cash flow was $3.22 million while its capital expenditure stood at $1.10 million.

Comparatively, OPTIMIZERx Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$7.73
52-Week High
$22.77
52-Week Low
$7.24
Analyst Target Price
$21.5

OPTIMIZERx Corp stock is currently trading at $7.73 per share. It touched a 52-week high of $22.77 and a 52-week low of $22.77. Analysts tracking the stock have a 12-month average target price of $21.5.

Its 50-day moving average was $11.69 and 200-day moving average was $14.9 The short ratio stood at 6.68 indicating a short percent outstanding of 0%.

Around 454.8% of the company’s stock are held by insiders while 8389.2% are held by institutions.

Frequently Asked Questions About OPTIMIZERx Corp

The stock symbol (also called stock or share ticker) of OPTIMIZERx Corp is OPRX

The IPO of OPTIMIZERx Corp took place on 1996-10-22

Similar Industry Stocks (Health Information Services)

Last Price
Chg
Chg%
$1.57
-0.03
-1.88%
$266.55
-10.95
-3.95%
BayCom Corp (BCML)
$19.12
0.08
+0.42%
$7.14
0.05
+0.71%
$145.95
-4.55
-3.02%
$0.18
0.02
+9.72%
BOSCH LTD. (BOSCHLTD)
$19148
-302.3
-1.55%
$36.09
-0.02
-0.06%
$81.73
-1.66
-1.99%
$13.39
0.85
+6.78%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.

Address

400 Water Street, Rochester, MI, United States, 48307